Mary J. Berg

1.4k total citations
37 papers, 1.0k citations indexed

About

Mary J. Berg is a scholar working on Pediatrics, Perinatology and Child Health, Rheumatology and Psychiatry and Mental health. According to data from OpenAlex, Mary J. Berg has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pediatrics, Perinatology and Child Health, 10 papers in Rheumatology and 10 papers in Psychiatry and Mental health. Recurrent topics in Mary J. Berg's work include Pharmacological Effects and Toxicity Studies (12 papers), Folate and B Vitamins Research (9 papers) and Epilepsy research and treatment (8 papers). Mary J. Berg is often cited by papers focused on Pharmacological Effects and Toxicity Studies (12 papers), Folate and B Vitamins Research (9 papers) and Epilepsy research and treatment (8 papers). Mary J. Berg collaborates with scholars based in United States. Mary J. Berg's co-authors include Marietta Anthony, Dorothy D. Schottelius, William G. Berlinger, Reynold Spector, George F. Johnson, Mark J. Goldberg, Don C. Van Dyke, Phyllis J. Stumbo, Dale Eric Wurster and Peter Veng‐Pedersen and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Pharmaceutical Research.

In The Last Decade

Mary J. Berg

37 papers receiving 963 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary J. Berg United States 17 281 221 155 146 142 37 1.0k
Suman Wason United States 22 124 0.4× 290 1.3× 119 0.8× 41 0.3× 105 0.7× 47 1.1k
M. Ehrnebo Sweden 25 304 1.1× 45 0.2× 156 1.0× 98 0.7× 329 2.3× 45 1.6k
Lena Palmér Sweden 20 165 0.6× 73 0.3× 114 0.7× 106 0.7× 231 1.6× 45 1.3k
Ahuva Golik Israel 24 141 0.5× 125 0.6× 95 0.6× 48 0.3× 192 1.4× 92 1.8k
A.R.W. Forrest United Kingdom 17 88 0.3× 215 1.0× 162 1.0× 35 0.2× 203 1.4× 43 1.1k
K. J. Berg Norway 31 245 0.9× 192 0.9× 182 1.2× 129 0.9× 272 1.9× 108 3.2k
G N Volans United Kingdom 22 180 0.6× 538 2.4× 322 2.1× 25 0.2× 201 1.4× 78 1.5k
Laurence Labat France 23 121 0.4× 57 0.3× 91 0.6× 96 0.7× 194 1.4× 119 1.8k
Micaela M.-T. Buckley Malaysia 22 172 0.6× 70 0.3× 143 0.9× 60 0.4× 389 2.7× 24 2.1k
Steven E. Aks United States 19 81 0.3× 390 1.8× 157 1.0× 40 0.3× 149 1.0× 60 1.4k

Countries citing papers authored by Mary J. Berg

Since Specialization
Citations

This map shows the geographic impact of Mary J. Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary J. Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary J. Berg more than expected).

Fields of papers citing papers by Mary J. Berg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary J. Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary J. Berg. The network helps show where Mary J. Berg may publish in the future.

Co-authorship network of co-authors of Mary J. Berg

This figure shows the co-authorship network connecting the top 25 collaborators of Mary J. Berg. A scholar is included among the top collaborators of Mary J. Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary J. Berg. Mary J. Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anthony, Marietta & Mary J. Berg. (2002). Biologic and Molecular Mechanisms for Sex Differences in Pharmacokinetics, Pharmacodynamics and Pharmacogenetics: Part II. Journal of Women s Health & Gender-Based Medicine. 11(7). 617–629. 44 indexed citations
2.
Anthony, Marietta & Mary J. Berg. (2002). Biologic and Molecular Mechanisms for Sex Differences in Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics: Part I. Journal of Women s Health & Gender-Based Medicine. 11(7). 601–615. 81 indexed citations
3.
Berg, Mary J., et al.. (2001). Folate, Zinc, and Vitamin B-12 Intake During Pregnancy and Postpartum. Journal of the American Dietetic Association. 101(2). 242–245. 10 indexed citations
4.
Dyke, Don C. Van, et al.. (1998). Drug and Environmental Factors Associated with Adverse Pregnancy Outcomes Part I: Antiepileptic Drugs, Contraceptives, Smoking, and Folate. Annals of Pharmacotherapy. 32(7-8). 802–817. 33 indexed citations
5.
Berg, Mary J.. (1997). Status of Research on Gender Differences. Journal of the American Pharmaceutical Association (1996). 37(1). 43–56. 11 indexed citations
6.
Berg, Mary J.. (1996). Infantile Spasms and West Syndrome. Archives of Neurology. 53(4). 299–299. 2 indexed citations
7.
Dyke, Don C. Van, et al.. (1995). Phenytoin-Folic Acid Interaction. Annals of Pharmacotherapy. 29(7-8). 726–735. 47 indexed citations
8.
Berg, Mary J., et al.. (1995). Folic Acid improves Phenytoin Pharmacokinetics. Journal of the American Dietetic Association. 95(3). 352–356. 11 indexed citations
9.
Modi, Nishit B., P. Veng‐Pedersen, Dale Eric Wurster, Mary J. Berg, & Dorothy D. Schottelius. (1994). Phenobarbital removal characteristics of three brands of activated charcoals: a system analysis approach.. Pharmaceutical Research. 11(2). 318–323. 3 indexed citations
10.
Berg, Mary J., et al.. (1992). Phenytoin Pharmacokinetics: Before and After Folic Acid Administration. Epilepsia. 33(4). 712–720. 13 indexed citations
11.
Wurster, Dale Eric, et al.. (1988). Phenobarbital Adsorption from Simulated Intestinal Fluid, U.S.P., and Simulated Gastric Fluid, U.S.P., by Two Activated Charcoals. Pharmaceutical Research. 5(3). 183–186. 25 indexed citations
12.
Berg, Mary J., et al.. (1988). Decrease of Serum Folates in Healthy Male Volunteers Taking Phenytoin. Epilepsia. 29(1). 67–73. 11 indexed citations
13.
Berg, Mary J., et al.. (1987). Phenytoin Binding in Healthy Volunteers. Therapeutic Drug Monitoring. 9(4). 384–388. 4 indexed citations
14.
Berg, Mary J., et al.. (1987). Parkinsonism—Drug Treatment: Part I. Drug Intelligence & Clinical Pharmacy. 21(1). 10–21. 9 indexed citations
15.
Berg, Mary J., et al.. (1987). Utilization of Km for Phenytoin Dosage after Folate Addition to Patient Regimen. Therapeutic Drug Monitoring. 9(3). 304–305. 13 indexed citations
16.
Gillespie, William R., Peter Veng‐Pedersen, Mary J. Berg, & Dorothy D. Schottelius. (1986). Linear systems approach to the analysis of an induced drug removal process. Phenobarbital removal by oral activated charcoal. Journal of Pharmacokinetics and Biopharmaceutics. 14(1). 19–28. 11 indexed citations
17.
Taylor, Jerry W., et al.. (1983). Phenytoin dosage requirements and pharmacokinetic variables.. PubMed. 2(3). 253–7. 6 indexed citations
18.
Perry, P. J., et al.. (1981). Lithium kinetics in single daily dosing. Acta Psychiatrica Scandinavica. 64(4). 281–294. 39 indexed citations
19.
Cerra, Frank B., et al.. (1980). Dose and serum concentration relationships in cimetidine-associated mental confusion. Gastroenterology. 78(4). 791–795. 49 indexed citations
20.
Berg, Mary J., et al.. (1980). Erythrocyte Lithium and the Erythrocyte: Plasma Lithium Ratio as Indicators of Mood Changes: Preliminary Report. Drug Intelligence & Clinical Pharmacy. 14(12). 836–841. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026